95 related articles for article (PubMed ID: 31804721)
1. Role of the N-Terminal Transmembrane Helix Contacts in the Activation of FGFR3.
Matsuoka D; Kamiya M; Sato T; Sugita Y
J Comput Chem; 2020 Mar; 41(6):561-572. PubMed ID: 31804721
[TBL] [Abstract][Full Text] [Related]
2. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
3. Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.
Volynsky PE; Polyansky AA; Fakhrutdinova GN; Bocharov EV; Efremov RG
J Am Chem Soc; 2013 Jun; 135(22):8105-8. PubMed ID: 23679838
[TBL] [Abstract][Full Text] [Related]
4. Coupling of transmembrane helix orientation to membrane release of the juxtamembrane region in FGFR3.
Tamagaki H; Furukawa Y; Yamaguchi R; Hojo H; Aimoto S; Smith SO; Sato T
Biochemistry; 2014 Aug; 53(30):5000-7. PubMed ID: 25010350
[TBL] [Abstract][Full Text] [Related]
5. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S; Hristova K
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
[TBL] [Abstract][Full Text] [Related]
6. Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies.
Bocharov EV; Lesovoy DM; Goncharuk SA; Goncharuk MV; Hristova K; Arseniev AS
Structure; 2013 Nov; 21(11):2087-93. PubMed ID: 24120763
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary dimer interfaces of the fibroblast growth factor receptor 3 transmembrane domain: characterization via multiscale molecular dynamics simulations.
Reddy T; Manrique S; Buyan A; Hall BA; Chetwynd A; Sansom MS
Biochemistry; 2014 Jan; 53(2):323-32. PubMed ID: 24397339
[TBL] [Abstract][Full Text] [Related]
8. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
Sarabipour S; Hristova K
J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
[TBL] [Abstract][Full Text] [Related]
9. FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.
He L; Shobnam N; Wimley WC; Hristova K
J Biol Chem; 2011 Apr; 286(15):13272-81. PubMed ID: 21324899
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation.
Monsonego-Ornan E; Adar R; Feferman T; Segev O; Yayon A
Mol Cell Biol; 2000 Jan; 20(2):516-22. PubMed ID: 10611230
[TBL] [Abstract][Full Text] [Related]
12. Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report.
Nagata T; Matsushita M; Mishima K; Kamiya Y; Kato K; Toyama M; Ogi T; Ishiguro N; Kitoh H
Mol Genet Genomic Med; 2020 Mar; 8(3):e1148. PubMed ID: 31975530
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic A391E mutation in FGFR3 induces a structural change in the transmembrane domain dimer.
Mudumbi KC; Julius A; Herrmann J; Li E
J Membr Biol; 2013 Jun; 246(6):487-93. PubMed ID: 23727984
[TBL] [Abstract][Full Text] [Related]
14. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.
Sarabipour S; Hristova K
Biophys J; 2013 Jul; 105(1):165-71. PubMed ID: 23823235
[TBL] [Abstract][Full Text] [Related]
15. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
16. Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants.
Hartl I; Brumovska V; Striedner Y; Yasari A; Schütz GJ; Sevcsik E; Tiemann-Boege I
J Biol Chem; 2023 Feb; 299(2):102832. PubMed ID: 36581204
[TBL] [Abstract][Full Text] [Related]
17. Hill coefficient analysis of transmembrane helix dimerization.
Soong R; Merzlyakov M; Hristova K
J Membr Biol; 2009 Jul; 230(1):49-55. PubMed ID: 19603128
[TBL] [Abstract][Full Text] [Related]
18. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
19. Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia.
Lee YC; Song IW; Pai YJ; Chen SD; Chen YT
Sci Rep; 2017 Feb; 7():43220. PubMed ID: 28230213
[TBL] [Abstract][Full Text] [Related]
20. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.
Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M
Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
